Summary
Results from an FDA-approved, prospective pilot trial suggest that the use of a self-expanding, intracranial stent for acute stroke may achieve high levels of revascularization. This follows on the heels of the Mechanical Embolus Removal in Cerebral Ischemia [MERCI; NCT00318071] trials that reported recanalization rates that ranged from approximately 60% to 70% percent with low associated morbidity.
- Cerebrovascular Disease Clinical Trials
- Interventional Techniques & Devices
Article Notes
- © 2009 MD Conference Express
Tools
Final Results of an FDA-approved Prospective, Multicenter, Single-Arm Trial of Stent-Assisted Recanalization for Acute Ischemic Stroke
Permalink:
Table of contents
Cited By...
- No citing articles found.